Literature DB >> 22045018

Agreement comparison between home and clinic blood pressure measurements in 200 Chinese participants.

Wen Wang1, Jin-Xiang Xie, Li Liu, Xiu-Hua Ai, Juan Zhang, Jun-Ying Sun, Shu-Yu Wang, Zhuo Shang, Li-Sheng Liu, Gus Q Zhang, Weiguo Zhang.   

Abstract

OBJECTIVE: The aim of the present study was to evaluate the agreement, mean difference, prevalence, and control rates of arterial hypertension between clinic (i.e. office) and home blood pressure (BP) measurements in a general population. Variations in home BP between morning and evening measurements and the dynamic changes during 7 days of measurements were also examined.
METHODS: A total of 200 participants were selected from three communities in the Beijing area. Patients underwent a clinical interview and measurement of both clinic and home BP. Thresholds for elevated clinic and home BP were defined as at least 140/90 and 135/85 mmHg.
RESULTS: Systolic and diastolic BP measured at clinic was higher than at home; the mean difference was 3.1/1.6 mmHg in all participants and 6.2/1.1 mmHg in hypertensive patients. With home BP monitoring, the first day of monitoring showed the highest and most varied (as reflected by standard deviation) BP readings. Home diastolic BP was significantly higher in the morning (76.6 ± 10.1 mmHg) than in the evening (74.2 ± 9.8 mmHg, P<0.0001), but home systolic BP was not. The prevalence of hypertension was higher when estimated by clinic versus by home BP (53.0 vs. 39.6%, P=0.025); and the control rate of hypertension tended to be lower when estimated by clinic versus by home BP (56.1 vs. 64.1%, P=0.24). The overall agreement between clinic and home BP in diagnosis of hypertension was 80.3% (κ coefficient: 0.6).
CONCLUSION: The present study in 200 Chinese demonstrates that BP is higher (a) at the clinic setting compared with at home and (b) on the first day of initiating home BP monitoring. There is moderate agreement between clinic and home BP in diagnosing hypertension. As home BP measurements may best represent the 'true' BP level in normotensives and hypertensives, its use in clinical practice should be promoted.

Entities:  

Mesh:

Year:  2011        PMID: 22045018     DOI: 10.1097/MBP.0b013e32834e3ba6

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

1.  Comparison of blood pressure measurements obtained in the home setting: analysis of the Health Measures at Home Study.

Authors:  Tatiana Nwankwo; Renee Gindi; Te-Ching Chen; Adena Galinsky; Ivey Miller; Ana Terry
Journal:  Blood Press Monit       Date:  2016-12       Impact factor: 1.444

2.  Nonpharmacological Correction of Hypersympatheticotonia in Patients with Chronic Coronary Insufficiency and Severe Left Ventricular Dysfunction.

Authors:  Sergey A Afanasiev; Elena N Pavliukova; Maria A Kuzmichkina; Tatiana Yu Rebrova; Yana Anfinogenova; Konstantin S Likhomanov; Rostislav S Karpov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-07       Impact factor: 1.468

3.  "Do it-yourself": Home blood pressure as a predictor of traditional and everyday cognition in older adults.

Authors:  Sophie E Yeung; Wendy Loken Thornton
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

4.  Comparative analysis of visit and home blood pressure in a pilot trial on the effect of 18% sodium substitute salt on blood pressure.

Authors:  Ting Liu; Huakun Rao; Meixian Wang; Huini Xu; Wen Wang; Ge Li; Hao Wang; Lihong Mu
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 5.  2019 Chinese Hypertension League guidelines on home blood pressure monitoring.

Authors:  Ji-Guang Wang; Pei-Li Bu; Lu-Yuan Chen; Xin Chen; Yuan-Yuan Chen; Wen-Li Cheng; Shao-Li Chu; Zhao-Qiang Cui; Qiu-Yan Dai; Ying-Qing Feng; Xiong-Jing Jiang; Yi-Nong Jiang; Wei-Hua Li; Yan Li; Yong Li; Jin-Xiu Lin; Jing Liu; Jian-Jun Mu; Ying-Xin Peng; Lei Song; Ning-Ling Sun; Yan Wang; Yang Xi; Liang-Di Xie; Hao Xue; Jing Yu; Wei Yu; Yu-Qing Zhang; Zhi-Ming Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.